Therapeutic indications

Aminophylline is indicated for:

Pulmonary oedema, paroxysmal nocturnal dyspnoea, status asthmaticus, acute bronchospasm

Population group: both men and women, only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Aminophylline is indicated for diseases of the cardiovascular system (e.g. an adjunct in the treatment of pulmonary oedema or paroxysmal nocturnal dyspnoea caused by left ventricular heart failure), reversible airways obstruction including status asthmaticus and acute bronchospasm.

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Aminophylline is contraindicated in the following cases:

Acute porphyria

Acute intermittent porphyria

Xanthine derivatives

at least one of
Xanthine derivatives

Xanthine derivatives

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines